Standard of Care Versus Urine Testing With Selective PHarmacogenomics for Effective Drug and Dosing REgimens

NCT02625155 · clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
14000
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

InSource Diagnostics

Collaborators